MRl of prostate cancer antigen expression for diagnosis and immunotherapy.

MRl of prostate cancer antigen expression for diagnosis and immunotherapy.

BACKGROUND: Tumor antigen (TA)-targeted monoclonal antibody (mAb) immunotherapy can be effective for the treatment of a broad range of cancer etiologies; however, these approaches have demonstrated variable clinical efficacy for the treatment of patients with prostate cancer (PCa). An obstacle curre...

Full description

Bibliographic Details
Main Authors: Jing Ren, Fang Wang, Guangquan Wei, Yong Yang, Ying Liu, Mengqi Wei, Yi Huan, Andrew C Larson, Zhuoli Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3384648?pdf=render

Internet

http://europepmc.org/articles/PMC3384648?pdf=render

Similar Items